Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. - Rachman,J.; Barrow,B.A.; Levy,J.C.; Turner,R.C. (Diabetologia, 1997)